期刊文献+

腹膜硬化 被引量:1

下载PDF
导出
作者 范敏华
出处 《生物医学工程与临床》 CAS 2001年第1期55-57,共3页 Biomedical Engineering and Clinical Medicine
  • 相关文献

同被引文献48

  • 1Kawanishi H,Harada Y,Noriyuki T,et al.Treatment options for encapsulating peritoneal sclerosis based on progressive stage.Adv Perit Dial,2001,17:200-204.
  • 2Klimopoulos S,Katsoulis IE,Margellos V,et al.Sclerosing encapsulating peritonitis secondary to CAPD:the effect of fibrotic debridement on further dialysis.JR Coll Surg Edinb,2002,47:485-490.
  • 3Kawaguchi H.Surgical treatment for encapsulating peritoneal sclerosis.Adv Perit Dial,2002,18:139-143.
  • 4Cancarini GC,Sandrini M,Vizzardi V,et al.Clinical aspects of peritoneal sclerosis.J-Nephrol,2001,14(Suppl 14):S39-47.
  • 5Carbonnel F,Barrie F,Beaugerie L,et al.Sclerosing peritonitis.A series of 10 cases and review of the literature(French).Gostroenterol Clin Biol,1995,19:876-882.
  • 6Okada K,Onishi Y,Oinuma T,et al.Sclerosing encapsulating peritonitis:regional changes of peritoneum.Nephron,2002,92:481-483.
  • 7Shao JC,Yorioka N,Nishida Y,et al.Effect of pH and glucose on cultured human peritoneal mesothelial cell.Scand J Urol Nephrol,1999,33:248-256.
  • 8Yoshindo K,Anders Traneus.A historical review of encapsulating peritoneal sclerosis.Perit Dial Int,2005,25(Suppl 4):S7-S13.
  • 9Breborowicz A,Rodela H,Oreopoulos DG.Toxicity of osmotic solutes on human mesothelial cells in vitro.Kidney Int,1992,41(5):1280-1284.
  • 10Nomoto Y,Kawaguchi Y,Sakai S,et al.Sclerosing encapsulating peritonitis(SEP) in patients on continuous ambulatory peritoneal dialysis-definition,diagnosis,and treatment recommendations,1997 update (Japanese).J Jpn Soc Dial Ther,1998,31:303-311.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部